Funding for this research was provided by:
capital foundation for clinical characteristics and application research (Z161100000516042)
capital medical development and research fund (2011-4025-04)
peking university clinical scientist program (BMU2019LCKXJ010)
Article History
Received: 28 June 2021
Accepted: 22 September 2021
First Online: 8 October 2021
Declarations
:
: This prospective study was registered at Chinese Clinical Trial Registry (ChiCTR-ONN-16009433) and approved by the Institutional Review Boards of the University Medical Ethics Committee (Approval Number: PKUSSIRB-201310068). Written informed consent was obtained from all participants following the guidelines of the committee for the research process.
: The authors declare no competing interests.